Navigation Links
$1,000,000 Global B.R.A.I.N. Prize Seeks Applicants
Date:2/6/2013

TEL AVIV, Israel, February 6, 2013 /PRNewswire/ --

Israel Brain Technologies (IBT) is seeking applicants for its $1,000,000 Global B.R.A.I.N. Prize competition. Applications will be accepted until March 15, 2013.

The Global B.R.A.I.N (Breakthrough Research And Innovation in Neurotechnology) Prize is an international R&D award to be granted to an individual, group or organization for a recent breakthrough in the field of brain technology.

The one-million-dollar prize will recognize a disruptive innovation on a path to commercialization with potentially significant impact to humanity. Innovations eligible for the award include:

1. Novel technologies that can augment scientific understanding of the brain

2. New technologies for the diagnosis and treatment of brain disease

3. Cutting-edge technologies to enhance human brain function

4. Groundbreaking Brain-Machine Interface technologies

5. Innovative brain stimulation technologies

6. Disruptive brain-inspired technologies in computation, communications and robotics

The prize will be awarded at IBT's Global Brain Technology Conference to be held in October, 2013. The prize is aimed at supporting further development of the winning technology.

Full contest details, terms and conditions as well as an application form can be found here.

The international judging committee is composed of distinguished leaders in neuroscience, technology and business, including three Nobel laureates: Profs. Eric Kandel , Daniel Kahneman and Bert Sakmann .

About Israel Brain Technologies

Israel Brain Technologies (IBT), a non-profit organization, has embarked upon a mission to advance the neurotechnology industry and establish Israel as a global epicenter of brain technology and related research.

IBT promotes multi-disciplinary research and development projects in Israel as well as collaboration between the Israeli brain ecosystem and the global community of researchers and innovators.

IBT was inspired by the vision of Israeli President Shimon Peres , a leading proponent of brain research and technology.

IBT is led by a team of technology entrepreneurs and life-science professionals, and is advised by a panel of renowned academic, industry and public sector representatives including Nobel laureates.

For more information, please visit: http://www.israelbrain.org/

CONTACT:
Miri Polachek
IBT Executive Director
miri@israelbrain.org
+972-3-6441735


'/>"/>
SOURCE Israel Brain Technologies (IBT)
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Julphar Extends its Global Footprint With Official Inauguration of Julphar Ethiopia Manufacturing Facility
2. Cynosure to Participate in Leerink Swann Global Healthcare Conference 2013
3. Solta Medical to Present at the Leerink Swann Global Healthcare Conference in New York on February 14, 2013
4. Monoclonal Antibody Industry 2013 Global and China Market Analysis in New Research Report at RnRMarketResearch.com
5. Luminex Corporation To Present At Leerink Swann Global Healthcare Conference
6. CBIS Releases Corporate Operational Guidance for 2013 as the Company Reorganizes to better meet the Growing Global Crisis Associated with Anti-Retroviral Drug Resistance among People with AIDS, as well as the Increasing Need for Patient Friendly Ski
7. Virile Numbers Showing up in the Global Male Grooming Products Market, sees Kline
8. Global Markets for Spectroscopy Equipment
9. The Indian Pharmaceutical Industry 2013: Coming of Age in a Global Market
10. Global BioClinical Awarded Cancer Genome Atlas (TCGA) Contract
11. Global Spinal Nonfusion Market to Grow to $1 Billion by 2017, Despite Challenges
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/20/2017)... , April 20, 2017 ... "Global Biosimilar Pipeline and Market Prospects: Addressing Production ... report to their offering. ... "Global Biosimilar Pipeline and Market Prospects: ... Design" provides an in-depth assessment of the current trends ...
(Date:4/20/2017)... April 20, 2017  AbbVie (NYSE: ABBV), a ... (n=145/146) of chronic hepatitis C virus (HCV) infected ... 6 and compensated cirrhosis (Child-Pugh A) achieved sustained ... ) with its investigational, pan-genotypic regimen of glecaprevir/pibrentasvir ... seen following 12 weeks of G/P treatment without ...
(Date:4/19/2017)... CRH) (NYSE MKT: CRHM) (the "Company"), announces that it will participate ... the Sheraton Hotel in Toronto, Ontario . ... is scheduled to present on Tuesday, May 2 at 10:00 am. ... the Board, Tony Holler will also attend the event. ... For more details about the ...
Breaking Medicine Technology:
(Date:4/28/2017)... York, New York (PRWEB) , ... April 28, ... ... high-quality anti-aging skincare and advanced nutraceutical supplements, through its Nova Skin ... cream provides the hydrating benefits of a moisturizer with the power of an ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... Christie ... today announced an alliance with B. Braun Medical Inc. , a leader in ... in patient care with as many as 90 percent of hospital patients receiving a ...
(Date:4/27/2017)... ... April 27, 2017 , ... Thinksport, the leaders in safe, ... award-winning sunscreen they’ve used the same scientific approach to solving smelly, sweaty athletes, ... the aisles that contain harmful chemicals that should be put nowhere near your ...
(Date:4/27/2017)... ... April 27, 2017 , ... Goodcents Deli Fresh Subs announced a franchise expansion ... this year. , The first new location will open at the corner of ... 84th and Northern Lights Drive this fall. And the third location is in the ...
(Date:4/26/2017)... , ... April 26, 2017 , ... ... supply management in hospitals, today announced it has completed a round of funding ... Capital LLC and its partners. Black Granite Capital is a growth equity firm ...
Breaking Medicine News(10 mins):